تخطي إلى المحتوى الرئيسي

mechanistic target of rapamycin kinase

ال MTOR gene provides instructions for making a protein called mTOR. This protein is found in various cell types throughout the body including brain cells. It interacts with other proteins to form two distinct protein groups, called mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). Both of these complexes transmit signals that direct the cells' function. Signaling through mTORC1 and mTORC2 regulate protein production, which influences cell growth, division, and survival. This mTOR signaling is especially important for growth and development of the brain, and it plays a role in a process called synaptic plasticity, which is the ability of the connections between nerve cells (synapses) to change and adapt over time in response to experience. Synaptic plasticity is critical for learning and memory.

اختيارات الفيديو لـ Genes
مكتبة الفيديو

Normal function

ال MTOR gene provides instructions for making a protein called mTOR. This protein is found in various cell types throughout the body including brain cells. It interacts with other proteins to form two distinct protein groups, called mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). Both of these complexes transmit signals that direct the cells' function. Signaling through mTORC1 and mTORC2 regulate protein production, which influences cell growth, division, and survival. This mTOR signaling is especially important for growth and development of the brain, and it plays a role in a process called synaptic plasticity, which is the ability of the connections between nerve cells (synapses) to change and adapt over time in response to experience. Synaptic plasticity is critical for learning and memory.

Conditions referring to this gene or chromosome

Other names

FK506 binding protein 12-rapamycin associated protein 2

FK506-binding protein 12-rapamycin complex-associated protein 1

FKBP-rapamycin associated protein

FKBP12-rapamycin complex-associated protein 1

FLJ44809

FRAP

FRAP1

FRAP2

mammalian target of rapamycin

mechanistic target of rapamycin (serine/threonine kinase)

RAFT1

rapamycin and FKBP12 target 1

rapamycin associated protein FRAP2

rapamycin target protein 1

RAPT1

serine/threonine-protein kinase mTOR

SKS

Related patient information and medicines

سرطان الفم

Patient information leaflet

سرطان الفم

Diagnosing mouth cancer Your healthcare professional may suspect mouth cancer if you have a lesion in your mouth (such as a sore, an ulcer or a lump) which has not healed for 3 wee... Dr Krishna Vakharia , 16th October 2023 The National Institute for Health and Care Excellence (NICE) has recommended that a person should receive a diagnosis or.

سرطان الكلى

Patient information leaflet

سرطان الكلى

The mos... If kidney cancer is diagnosed at an early stage, there is a good chance of a cure. A description of what kidneys are and how they work is at the bottom of this article. What is kidney cancer. There are several types of kidney cancer but over 9 out of 10 kidney cancers are "renal cell cancer". This is sometimes called renal.

اضطرابات الغدة النخامية

Patient information leaflet

اضطرابات الغدة النخامية

This leaflet gives a brief overview of the pituitary gland و the hormones it makes. The pituitary gland is found at the base of the brain and is 'pea-sized'. The pituitary gland is an overall controller of a number of other glands in the body, overseeing the function of these organs through hormones. Some of the pituitary gland disorders.

الأدوية البيولوجية لالتهاب المفاصل الروماتويدي

Patient information leaflet

الأدوية البيولوجية لالتهاب المفاصل الروماتويدي

Biological medicines are a newer type of medicine, used to ease the symptoms of التهاب المفاصل الروماتويدي and reduce the damaging effect of the disease on the joints. They are usually prescribed when you have tried older medicines called disease-modifying antirheumatic drugs (DMARDs) and these have not worked so well. If a biological medicine is going.

سرطان الكبد الأولي

Patient information leaflet

سرطان الكبد الأولي

It is not likely to be curative for primary liver cancer but may shrink the tumour down to slow the progression of the disease. There are new medicines being developed for the treatment of liver cancer. For example, sorafenib is a type of medicine called a multi-targeted kinase inhibitor. It interferes with the growth of cancer cells. National.

داء الخلايا البدينة واضطرابات الخلايا البدينة

Patient information leaflet

داء الخلايا البدينة واضطرابات الخلايا البدينة

If the condition is severe, surgery to remove the spleen (splenectomy), medicines that have an effect on the immune system (such as interferon), bone marrow transplant or... Dr Sarah Jarvis , 28th September 2021 Midostaurin for treating advanced systemic mastocytosis The National Institute for Health and Care Excellence (NICE) has brought out new.

قراءة إضافية ومراجع

تاريخ المقال

تمت كتابة المعلومات على هذه الصفحة ومراجعتها من قبل أطباء مؤهلين.
  • 2 أغسطس 2023 | أحدث إصدار
  • 1 Jan 2019 | نُشر في الأصل

انضم إلى المحادثة

شارك أفكارك أو تجاربك مع الآخرين في مجتمعات المرضى.

تنويه: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

صيدلية إلكترونية وعلاجات وخدمات صحية

وصول بسيط إلى العلاجات والخدمات الصحية الموثوقة عبر الإنترنت.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

اشترك في النشرة الإخبارية للمرضى

جرعتك الأسبوعية من النصائح الصحية الواضحة والموثوقة - مكتوبة لمساعدتك على الشعور بالاطلاع والثقة والتحكم.

يرجى إدخال عنوان بريد إلكتروني صالح

من خلال الاشتراك، فإنك تقبل سياسة الخصوصية. يمكنك إلغاء الاشتراك في أي وقت. نحن لا نبيع بياناتك أبدًا.